G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,587 | -59.9% | 21,241 | -30.7% | 0.00% | – |
| Q2 2023 | $76,276 | +2.2% | 30,633 | +10.0% | 0.00% | – |
| Q1 2023 | $74,608 | -46.1% | 27,839 | +9.2% | 0.00% | – |
| Q4 2022 | $138,421 | -79.6% | 25,492 | -53.1% | 0.00% | – |
| Q3 2022 | $680,000 | +333.1% | 54,361 | +71.2% | 0.00% | – |
| Q2 2022 | $157,000 | -54.2% | 31,755 | -29.6% | 0.00% | – |
| Q1 2022 | $343,000 | -41.6% | 45,138 | -21.5% | 0.00% | – |
| Q4 2021 | $587,000 | -58.9% | 57,487 | -46.0% | 0.00% | – |
| Q3 2021 | $1,428,000 | -32.8% | 106,405 | +9.9% | 0.00% | – |
| Q2 2021 | $2,124,000 | +12.1% | 96,799 | +23.0% | 0.00% | – |
| Q1 2021 | $1,894,000 | +149.9% | 78,697 | +86.7% | 0.00% | – |
| Q4 2020 | $758,000 | +117.2% | 42,153 | +39.6% | 0.00% | – |
| Q3 2020 | $349,000 | -48.0% | 30,201 | +9.2% | 0.00% | – |
| Q2 2020 | $671,000 | +210.6% | 27,647 | +41.3% | 0.00% | – |
| Q1 2020 | $216,000 | -57.0% | 19,566 | +2.9% | 0.00% | – |
| Q4 2019 | $502,000 | +10.3% | 19,017 | -4.8% | 0.00% | – |
| Q3 2019 | $455,000 | +8.9% | 19,973 | +46.5% | 0.00% | – |
| Q2 2019 | $418,000 | +66.5% | 13,636 | -9.8% | 0.00% | – |
| Q1 2019 | $251,000 | -13.4% | 15,125 | -0.1% | 0.00% | – |
| Q4 2018 | $290,000 | -46.2% | 15,136 | +46.8% | 0.00% | – |
| Q3 2018 | $539,000 | +28.6% | 10,309 | +7.0% | 0.00% | – |
| Q2 2018 | $419,000 | +103.4% | 9,634 | +73.5% | 0.00% | – |
| Q1 2018 | $206,000 | +123.9% | 5,554 | +19.3% | 0.00% | – |
| Q4 2017 | $92,000 | +557.1% | 4,655 | +749.5% | 0.00% | – |
| Q3 2017 | $14,000 | – | 548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |